Full Text View
Tabular View
No Study Results Posted
Related Studies
Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
This study has been completed.
Study NCT00421473   Information provided by Radboud University
First Received: January 11, 2007   Last Updated: February 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Malaria
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
More general conditions related to this trial
Coccidiosis
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Parasitic Diseases
Protozoan Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Atovaquone / Proguanil
Additional drug interventions recognized in this trial
Anti-Retroviral Agents
Atovaquone
Chloroguanide
Malarone
More general drug interventions related to this trial
Anti-Infective Agents
Antimalarials
Antimetabolites
Antiparasitic Agents
Antiprotozoal Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Radboud University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services